When a Californian company founded by a U.S. veteran wounded in Afghanistan sought to register a new medical device this year, it turned to Europe before the United States. The European approvals system had long been quicker, the company said, but the introduction of new rules is changing all that.
Israel's Pitango Venture Capital said on Thursday it was launching a fund that will reach $150 million to invest in health technology.
Scoliosis is a condition in which the spine curves to either side. Exercise and stretches are a vital part of treatment and can help relieve pain. Learn about the best stretches and exercises for scoliosis here.
Feeling pain in the buttocks is common during pregnancy. Often, it is due to extra pressure from the growing uterus, which can cause sciatica or hemorrhoids. Here, learn about these and other sources of butt pain during pregnancy.
The Trump administration on Wednesday said it would end scientific research at the National Institutes of Health that relies on fetal tissue from elective abortions, and would accelerate efforts to find alternatives for such research, a move welcomed by anti-abortion groups.
Insys Therapeutics Inc agreed to pay $225 million and an operating unit will plead guilty to fraud to settle probes into their payment of kickbacks to induce doctors to prescribe highly addictive opioids, the U.S. Department of Justice said on Wednesday.
(Reuters Health) - Middle schools that offer a comprehensive dating violence prevention program in every grade may have fewer youth involved in abusive relationships, a U.S. study suggests.
Insys Therapeutics Inc agreed to pay $225 million and an operating unit agreed to plead guilty to five mail fraud counts to settle criminal and civil probes into its marketing of opioids, the U.S. Department of Justice said on Wednesday.
(Reuters Health) - U.S. soldiers are more likely to have poor heart health than civilians of similar ages, a new study finds.
Takeda Pharmaceutical Co Ltd said on Wednesday it would discontinue a late-stage study testing its experimental treatment for amyloidosis, as it did not meet the first of two main goals.